Jennifer L. Davis - 29 Apr 2025 Form 4 Insider Report for PROCTER & GAMBLE Co (PG)

Role
CEO - Health Care
Signature
/s/ Wednesday Shipp, attorney-in-fact for Jennifer L. Davis
Issuer symbol
PG
Transactions as of
29 Apr 2025
Net transactions value
-$161,384
Form type
4
Filing time
30 Apr 2025, 13:45:15 UTC
Previous filing
20 Dec 2024
Next filing
13 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PG Common Stock Sale $161,384 -1,000 -1.9% $161.38 51,965 29 Apr 2025 Direct F1, F2
holding PG Common Stock 14,838 29 Apr 2025 By Retirement Plan Trustee F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PG Restricted Stock Units Award $0 +22 +14% $0.000000 180 18 Feb 2025 Common Stock 22 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Weighted average price of the shares sold. The price range was $161.38 to $161.40. Full information regarding the number of shares sold at each separate price available upon request.
F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F3 Reflects adjustment to PST through March 31, 2025.
F4 Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F5 These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.